0001010412-02-000042 Sample Contracts
EXCLUSIVE LICENSE AGREEMENT for Sanguine Corporation Technologies PHER-02 Oxygen-Carrying Synthetic Substitute for Human Red Blood Cells U.S. Patent Pending, Assigned Serial Number 08/230,672 All Derivatives of PHER-02 TABLE OF CONTENTS RECITALS...Exclusive License Agreement • March 25th, 2002 • Sanguine Corp • In vitro & in vivo diagnostic substances • California
SUBSCRIPTION AGREEMENT Dear Subscriber: You (the "Subscriber") hereby agree to purchase, and Sanguine Corporation, a Nevada corporation (the "Company") hereby agrees to issue and to sell to the Subscriber, a 5% Convertible Note convertible in...Subscription Agreement • March 25th, 2002 • Sanguine Corp • In vitro & in vivo diagnostic substances • New York
FUNDS ESCROW AGREEMENT This Agreement is dated as of the 19 day of March, 2002 among Sanguine Corporation, a Nevada corporation (the "Company"), First York Partners, Inc. ("Subscriber"), and Grushko & Mittman, P.C. (the "Escrow Agent"): W I T N E S S...Funds Escrow Agreement • March 25th, 2002 • Sanguine Corp • In vitro & in vivo diagnostic substances • New York